Ferrer, an international B Corp pharmaceutical company with an increasing focus on rare neurological diseases, and Prilenia Therapeutics B.V., a clinical-stage biotech company, have announced the ...

Approximately 25% of women in the United States between ages 45 and 60 are at high risk for breast cancer and should consider ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin ...

India's drug regulatory body, CDSCO, has banned 35 fixed-dose combination drugs, including painkillers and anti-diabetics, due to safety concerns. These combinations were manufactured and sold ...

GSK said on Thursday two combination therapies with its cancer drug, Blenrep, have received approval from British authorities ...

If approved, Brimochol PF would be the first combination therapy for presbyopia. Perspective from Michael DeCourcey, MD Tenpoint Therapeutics submitted a new drug application to the FDA for ...

The German Institute for Quality and Efficiency in Health Care (IQWiG) has now examined in a benefit assessment whether the drug combination offers an added benefit for these patients in ...

The findings suggest that treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks over a decade.

Patients in a Phase 3 clinical trial who received sotorasib and panitumumab lived longer, suggesting the combination therapy could become the new standard of care, according to a new City of Hope ...

and a third group received either a trifluridine/tipiracil combination or regorafenib, the current standard of care drugs. “We confirmed that the higher dose of sotorasib was associated with higher ...